Emerging risks facing the life sciences industry and how companies can defend against them

Prior to COVID-19, life science companies anticipated playing an even greater role in strengthening the middle market. But with new growth comes new risks. (Photo: Fotolia)

The life sciences industry is a significant contributor to U.S. and Canadian economic growth and job creation. Primarily comprised of pharmaceutical, medical device, biotech, and dietary supplements companies, the middle-market life sciences industry has a revenue growth rate and employment growth rate well above the national average.

Want to continue reading?
Become a Free
PropertyCasualty360 Digital Reader.

INCLUDED IN A DIGITAL MEMBERSHIP:

• All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
• Educational webcasts, resources from industry leaders, and informative newsletters.
• Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.

Register Now

Already have an account? Sign In Now